SPU-16 is designed to cross the blood-brain barrier and target damaged tissue and inflammation. It has shown potential to enhance the therapeutic effect of current and future therapeutics while decreasing the toxicity of drugs, which could provide significant benefits for multiple sclerosis treatment.